Nonalcoholic fatty liver disease has been proposed to impair hepatic sensitivity to glucagon signaling, causing higher levels of fasting amino acid and glucagon levels (23, 31). The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.